This inventor holds 1 USPTO granted patent. Top assignee: Randox Laboratories Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Frank Emmert-Streib: Innovator in Bladder Cancer Diagnosis
Introduction
Frank Emmert-Streib is a notable inventor based in Belfast, GB. He has made significant contributions to the field of medical diagnostics, particularly in the area of bladder cancer. His innovative approach has the potential to improve patient outcomes through early detection and risk stratification.
Latest Patents
Frank Emmert-Streib holds a patent for a method titled "Diagnosis and risk stratification of bladder cancer." This invention provides a systematic approach to defining the likelihood of a subject having bladder cancer. The method involves specific steps that enhance the accuracy of diagnosis, ultimately benefiting patients and healthcare providers alike. He has 1 patent to his name.
Career Highlights
Emmert-Streib is associated with Randox Laboratories Limited, a company known for its commitment to advancing healthcare through innovative technologies. His work at Randox has allowed him to focus on developing cutting-edge diagnostic solutions that address critical health issues.
Collaborations
Throughout his career, Frank has collaborated with talented individuals such as Mark William Ruddock and Cherith N Reid. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Frank Emmert-Streib's contributions to bladder cancer diagnosis exemplify the impact of innovation in healthcare. His work not only enhances diagnostic accuracy but also paves the way for improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile